DRUG STUDY

Date Generic Brand Classificat Indication

Mechanism Dosage & Time Adverse Nursing
Name Name ion of Action Frequency Given Reaction Consideration
03-24- Trifluopera Apo- Therapeut Schizophr Alters the CNS: · Be alert for
21 zine Trifluoper ic: enia, effects of NEUROLE signs of
azine antipsych nonpsych dopamine PTIC neuroleptic
otics otic in the CNS. MALIGNAN malignant
(conventi anxiety. Possesses T syndrome,
onal) Considere significant SYNDROM including
d 2nd-line anticholiner E, hyperthermia,
Pharmaco treatment gic and extrapyrami diaphoresis,
logic: after alpha- dal generalized
phenothia failure adrenergic reactions, muscle rigidity,
zines with blocking sedation, altered mental
atypical activity. tardive status,
antipsych Therapeuti dyskinesia. tachycardia,
otics. c Effects: EENT: dry changes in
Diminished eyes, blood pressure
Unlabele signs and blurred (BP), and
d Use: symptoms vision, lens incontinence.
Other of opacities. Symptoms
psychotic psychoses. CV: typically occur
disorders; hypotensio within 4–14
bipolar n, days after
disorder. tachycardia initiation of
. GI: drug therapy,
constipatio but can occur at
n, anorexia, any time during
dry mouth, drug use.
hepatitis, Report these
ileus. GU: signs to the
urinary physician
retention, immediately.
priapism.
Derm: · Watch for
photosensit signs of
ivity, agranulocytosis
pigment and leukopenia,
changes, including fever,
rashes. sore throat,
Endo: mucosal
galactorrhe lesions, and
a, other signs of
amenorrhe infection.
a. Hemat: Report these